TY - JOUR
T1 - Estimating the client costs of addiction treatment
T2 - First findings from the client drug abuse treatment cost analysis program (Client DATCAP)
AU - Salomé, Helena J.
AU - French, Michael T.
AU - Miller, Michael
AU - McLellan, A. Thomas
N1 - Funding Information:
Financial assistance for this study was provided by the National Institute on Drug Abuse (grant numbers 1R01 DA11506 and 2P50 DA07705) and the National Institute on Alcohol Abuse and Alcoholism (grant number 1 R01 AA13167-01). We are grateful to Silvana Zavala for research assistance throughout the study, Carri Brewer for her design work on the instruments, Jody Sindelar for helpful suggestions on earlier Editions of the Client DATCAP, three anonymous reviewers for excellent feedback on the original manuscript, and Carmen Martinez, William Russell, and Michelle Peart for their administrative and editorial assistance. This research was completed while Dr French was an Associate Professor at the Department of Epidemiology and Public Health and the Department of Economics, University of Miami, Miami, Florida. The authors are entirely responsible for the research conducted in this paper, and their position or opinions do not necessarily represent those of the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the University of Miami, the Medical University of South Carolina, The Village treatment organization, or the Treatment Research Institute.
PY - 2003/8/20
Y1 - 2003/8/20
N2 - The costs of addiction treatment services are an important determinant of the cost-effectiveness of a program, and therefore, of relevance to addiction treatment providers, insurance companies and, patients. Several methods have been developed to estimate the costs of substance abuse treatment services. One such method is the drug abuse treatment cost analysis program (DATCAP), which collects resource use and cost data from the treatment program perspective and has been used in numerous published economic evaluation studies. However, no single widely-used, standardized instrument is currently available to estimate costs specifically incurred by clients in treatment. In response to that need, this article introduces the Client DATCAP and presents process, survey-specific, and quantitative findings from a Pilot Study to estimate the client costs of attending outpatient and inpatient treatment. The preliminary findings suggest that the self-administered Client DATCAP is a feasible and practical instrument for estimating costs incurred by clients in treatment, with completion time amounting to less than 10 min. Furthermore, client costs had a considerable range across respondents, with time costs consistently accounting for the largest cost component. Findings from the Pilot Study led to the development and release of edition 2 of the outpatient and inpatient modules of the Client DATCAP.
AB - The costs of addiction treatment services are an important determinant of the cost-effectiveness of a program, and therefore, of relevance to addiction treatment providers, insurance companies and, patients. Several methods have been developed to estimate the costs of substance abuse treatment services. One such method is the drug abuse treatment cost analysis program (DATCAP), which collects resource use and cost data from the treatment program perspective and has been used in numerous published economic evaluation studies. However, no single widely-used, standardized instrument is currently available to estimate costs specifically incurred by clients in treatment. In response to that need, this article introduces the Client DATCAP and presents process, survey-specific, and quantitative findings from a Pilot Study to estimate the client costs of attending outpatient and inpatient treatment. The preliminary findings suggest that the self-administered Client DATCAP is a feasible and practical instrument for estimating costs incurred by clients in treatment, with completion time amounting to less than 10 min. Furthermore, client costs had a considerable range across respondents, with time costs consistently accounting for the largest cost component. Findings from the Pilot Study led to the development and release of edition 2 of the outpatient and inpatient modules of the Client DATCAP.
KW - Client DATCAP
KW - DATCAP
KW - Economic evaluation
KW - Treatment cost
UR - http://www.scopus.com/inward/record.url?scp=0142011996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142011996&partnerID=8YFLogxK
U2 - 10.1016/S0376-8716(03)00133-9
DO - 10.1016/S0376-8716(03)00133-9
M3 - Article
C2 - 12927658
AN - SCOPUS:0142011996
VL - 71
SP - 195
EP - 206
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
SN - 0376-8716
IS - 2
ER -